TrialAnnals of surgery2020

Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma.

Syed A Ahmad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.